Skip to content

Dogwood Therapeutics DWTX Total Current Assets

Total Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$54.84B+32.9%
Pfizer logo
PfizerPFE
$42.82B-6.6%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$11.73B+17.2%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$745.67M+41.3%
Bioventus logo
BioventusBVS
$249.81M+0.2%
Avanos Medical logo
Avanos MedicalAVNS
$325M-7.8%

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's total current assets?
Dogwood Therapeutics (DWTX) reported total current assets of $15M in Q1 2026.
How has Dogwood Therapeutics's total current assets changed year-over-year?
Dogwood Therapeutics's total current assets decreased by 21.7% year-over-year, from $19.16M to $15M.
What is the long-term trend for Dogwood Therapeutics's total current assets?
Over 5 years (2020 to 2025), Dogwood Therapeutics's total current assets has grown at a -23.2% compound annual growth rate (CAGR), from $31.47M to $8.43M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.